key: cord-0703732-hzv51czu
authors: Wei, Changshuo; Shan, Ke-Jia; Wang, Weiguang; Zhang, Shuya; Huan, Qing; Qian, Wenfeng
title: Evidence for a mouse origin of the SARS-CoV-2 Omicron variant
date: 2021-12-24
journal: J Genet Genomics
DOI: 10.1016/j.jgg.2021.12.003
sha: aabfb82d4cd3ca3ee03c2ad786942c1b720e1ab4
doc_id: 703732
cord_uid: hzv51czu

The rapid accumulation of mutations in the SARS-CoV-2 Omicron variant that enabled its outbreak raises questions as to whether its proximal origin occurred in humans or another mammalian host. Here, we identified 45 point mutations that Omicron acquired since divergence from the B.1.1 lineage. We found that the Omicron spike protein sequence was subjected to stronger positive selection than that of any reported SARS-CoV-2 variants known to evolve persistently in human hosts, suggesting a possibility of host-jumping. The molecular spectrum of mutations (i.e., the relative frequency of the 12 types of base substitutions) acquired by the progenitor of Omicron was significantly different from the spectrum for viruses that evolved in human patients, but resembled the spectra associated with virus evolution in a mouse cellular environment. Furthermore, mutations in the Omicron spike protein significantly overlapped with SARS-CoV-2 mutations known to promote adaptation to mouse hosts, particularly through enhanced spike protein binding affinity for the mouse cell entry receptor. Collectively, our results suggest that the progenitor of Omicron jumped from humans to mice, rapidly accumulated mutations conducive to infecting that host, then jumped back into humans, indicating an inter-species evolutionary trajectory for the Omicron outbreak.

The coronavirus disease 2019 (COVID-19) pandemic, caused by the SARS-CoV-2 RNA 33 virus, has led to significant illness and death worldwide. The SARS-CoV-2 Omicron 34 variant was first reported in South Africa on November 24 th , 2021, and was designated as 35 a variant of concern (VOC) within two days by the World Health Organization (WHO) 36 based on the increase in infections attributable to this variant in South Africa (i.e., The first two hypotheses assume that Omicron acquired these mutations in humans 58 (collectively referred to as "human origin hypothesis" hereafter), while the third assumes 59 that Omicron acquired mutations in a nonhuman species. Based on our previous work in 60 J o u r n a l P r e -p r o o f viral evolution, we hypothesized that the host species in which Omicron acquired its 61 particular set of mutations could be determined by analyzing the molecular spectra of 62 mutations (i.e., the relative frequency of the 12 types of base substitutions). In previous 63 work, we showed that de novo mutations in RNA virus genomes are generated in a In this study, we identified mutations acquired by Omicron before its outbreak, and tested 79 whether the molecular spectrum of these mutations was consistent with the cellular 80 environment of human hosts. Prominent dissimilarities were observed between the 81 molecular spectrum of Omicron and a relatively comprehensive set of molecular spectra 82 from variants known to have evolved in humans, including those of three isolates from 83 chronic COVID-19 patients. Therefore, we next examined the molecular spectra of 84 mutations obtained from a wide range of host mammals for comparison with that of 85 Omicron. Finally, we used molecular docking-based analyses to investigate whether the 86 mutations in the Omicron spike protein could be associated with adaptation to the host 87 species inferred from molecular spectrum analysis. Our study provides insight into the (Fig. 1A) . We hereafter refer to this long branch as Branch O. 104 We identified 45 point mutations that were introduced in Branch O (hereafter referred to 105 as "pre-outbreak Omicron mutations"; Fig. S1 ). We observed that the pre-outbreak to compare mutation accumulation rates among different variants. We found that spanning May 2020-November 2021, equivalent to ~1.5 mutations per month, or ~3.3 121 times faster than the average rate of other variants (Fig. 1C) .

Counting mutations across the whole SARS-CoV-2 genome indicated that Omicron 123 acquired mutations in the genome at a similar rate to other variants (Fig. 1D) , suggesting 124 that the accelerated evolutionary rate of ORF S could not be explained by an overall 125 elevated mutation rate in Omicron progenitors. In light of these findings, we To exclude the possibility that this apparent difference in the molecular spectrum was 165 caused by the relatively small number of pre-outbreak Omicron mutations, we generated (Table S1) however, they too showed substantially lower odds ratios and significance levels than 254 those isolated from mice (Fig. 4C) . These observations implied that the pre-outbreak 255 Omicron mutations in ORF S promoted its adaptation to a mouse host. 256 We then conducted enrichment analysis for each of the seven mouse-adapted SARS-257 CoV-2 variants and observed statistical significance for all these variants (Fig. 4D) . In The molecular docking-based predictions suggested that the RBD of Omicron exhibited 291 higher binding affinity for mouse ACE2 than that of RBD encoded in the reference 292 SARS-CoV-2 genome, further suggesting an evolutionary history in mice (Fig. 5B) . And 293 as expected, the mutations detected in the RBD of the other four VOCs of SARS-CoV-2 as well as those of variants isolated from chronically infected human patients showed no 295 apparent changes in their binding affinity for mouse ACE2 compared with the reference 296 RBD (Fig. 5B ).

Since five amino acid mutations were shared between Omicron and mouse-adapted 298 SARS-CoV-2 variants in RBD (i.e., K417N, E484A, Q493R, Q498R, and N501Y; Fig.   299 4B), and that they together enhanced RBD binding affinity for mouse ACE2 (Fig. 5B) , (Fig. 5B) . By contrast, the other three mutations showed no significant 306 effects on the binding affinity between RBD and mouse ACE2, neither in the reference 307 RBD nor in the Q493R/Q498R double mutant (Fig. 5B) , suggesting that they did not 308 contribute to the enhanced interaction between Omicron RBD and mouse ACE2. We with the ACE2 of that host. To test this prediction, we applied molecular docking 322 analysis to ACE2 from 31 other species, representing markedly different mammalian lineages (Kumar et al., 2017) . We found that, compared with the RBD encoded in the 324 reference genome, the Omicron RBD showed the highest ACE2-interaction enhancement 325 with mice among all these mammals (Fig. 6) , suggesting that mice were the most likely 326 host species to influence the evolution of the progenitor of Omicron. In this study, we used the molecular spectrum of mutations of the SARS-CoV-2 Omicron 330 variant to trace its proximal host origins. We found that the molecular spectrum of pre- Omicron. Furthermore, the molecular spectrum of these 31 mutations in Omicron was 352 also significantly different from the hSCV2 spectrum (P = 0.008, G-test; Fig. S5 ), 353 suggesting that these backbone mutations were not acquired in humans. The molecular docking-based predictions showed that the adaptation of Omicron to mice 379 also promoted its adaptation to other species, such as humans, camels, and goats, via 380 stronger RBD-ACE2 interaction (Fig. 6) . Such a "pleiotropic effect" of mutations was 381 likely caused by structural similarity of ACE2 across species, and indicates that once a (Table S1 ). These coronaviruses were chosen from coronaviruses recorded in the 444 International Committee on Taxonomy of Viruses (https://talk.ictvonline.org/taxonomy/).

All mammalian coronaviruses were retrieved, and only those with at least ten reported 446 sequences were used, to ensure accurate estimation of the molecular spectrum. If there 447 were multiple coronaviruses infecting the same host species, we randomly chose one for 448 the subsequent analyses. The molecular spectra of accumulated mutations in the 449 coronaviruses that infected bats, camels, or humans were retrieved from a previous study 450 (Shan, et al., 2021) .

The virus genome sequences were aligned by MUSCLE, and the phylogenetic trees and 452 ancestral sequences were reconstructed using FastML. Since the roots of these 453 phylogenetic trees were not readily identified, we kept only external branches to ensure 454 J o u r n a l P r e -p r o o f the correction direction of base substitutions (e.g., C>U vs. U>C). For the sake of clarity, 455 we showed the molecular spectra for five branches with the largest number of mutations 456 for each coronavirus species in the main text. The full data set is available in Table S1 . 457 We characterized the molecular spectra of mutations accumulated in chronically infected 458 patients, in which single-nucleotide base substitutions that ever occurred during the 459 monitored period were counted. We downloaded the genomic sequences of four variants 460 (EPI_ISL_5803018, EPI_ISL_3730369, EPI_ISL_4003132, and EPI_ISL_6260720), 461 each from one of the other four VOCs (Alpha, Beta, Gamma, and Delta, respectively), to 462 estimate the molecular spectra of mutations accumulated in VOCs.

Principal component analyses 464 We performed principal component analysis (prcomp function in R) with the proportions 465 of the 12 base-substitution types as the input, and then projected molecular spectra into a 466 two-dimensional space according to the first two principal components. To define the 467 borderlines of molecular spectra for each host species (i.e., cattle, bats, dogs, cats, mice, 468 pigs, or humans), we estimated the 95% confidence ellipses (stat_ellipse function in R) 469 from the molecular spectra of these host species. The spectra of pre-and post-outbreak 470 Omicron mutations were further projected into the same two-dimensional space. 473 We downloaded from GISIAD the genomic sequences of SARS-CoV-2 variants isolated 474 from 21 mammalian hosts (Tables S2 and S3) 521 The authors declare that they have no competing interests. Step 1: Constructing phylogenetic tree for coronaviruses isolated from each host taking canine (dog) coronaviruses for example

Step 2: Choosing molecular spectra of the five longest branches for each host Step 4: Performing principal component analysis for molecular spectra

Step 3: Retrieving previously reported molecular spectra of coronaviruses isolated from bats, camels, and humans, and estimating the molecular spectra of the other four VOCs (i.e., Alpha, Beta, Gamma, and Delta). Zhang et al.

Wong et al. 

Huang et al.

Wu et al. Sites shared with pre-outbreak Omicron mutations Sites not shared with pre-outbreak Omicron mutations 

FastML: a web server for probabilistic reconstruction of ancestral sequences

APOBEC-1-mediated RNA editing

Heavily mutated Omicron variant puts scientists on alert

SARS-CoV-2 exposure 543 in wild white-tailed deer (Odocoileus virginianus)

546 Mutation rates and selection on synonymous mutations in SARS-CoV-2

Mutation signatures inform the natural host of SARS-CoV-2

MUSCLE: A multiple sequence alignment method with reduced time and 551 space complexity

Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy

Nextstrain: real-time tracking of pathogen evolution

APOBECs and virus restriction

Virus variation resource -improved response to emergent viral 561 outbreaks

Q493K and Q498H substitutions in Spike promote adaptation of 564 SARS-CoV-2 in mice

Structural and functional properties of 566 SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19

Are scoring functions in protein-protein docking ready to 569 predict interactomes? Clues from a novel binding affinity benchmark

SARS-CoV-2 evolution during 573 treatment of chronic infection

The architecture of 575 SARS-CoV-2 transcriptome

Oxidative damage to RNA: Mechanisms, consequences, and diseases. 577 Cell Mol

TimeTree: A resource for timelines, 579 timetrees, and divergence times

Where did 'weird' Omicron come from?

SARS-CoV-2 spike protein predicted to 583 form complexes with host receptor protein orthologues from a broad range of mammals

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 587 receptor

A mouse-adapted SARS-CoV-2 induces acute 590 lung injury and mortality in standard laboratory mice

SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune 593 escape

RNA damage and surveillance under oxidative stress

SARS-CoV-2 vaccines based on the spike glycoprotein and 598 implications of new viral variants

A mouse-adapted SARS-CoV-2 601 strain replicating in standard laboratory mice. bioRxiv

Molecular 603 dynamic simulation reveals E484K mutation enhances spike RBD-ACE2 affinity and the 604 combination of E484K, K417N and N501Y mutations (501Y.V2 variant) induces 605 conformational change greater than N501Y mutant alone, potentially resulting in an 606 escape mutant. bioRxiv

609 Transmission of SARS-CoV-2 on mink farms between humans and mink and back to 610 humans

Excessive G-U transversions in novel allele variants in 612 SARS-CoV-2 genomes

Comparative analysis reveals the species-specific genetic determinants of ACE2 615 required for SARS-CoV-2 entry

Insights on cross-species transmission of SARS-CoV-2 from structural 618 modeling

Host-specific asymmetric accumulation 620 of mutation types reveals that the origin of SARS-CoV-2 is consistent with a natural 621 process. The Innovation 2

GISAID: Global initiative on sharing all influenza data -from 623 vision to reality

Tracking cryptic SARS-CoV-2 626 lineages detected in NYC wastewater. medRxiv

After the pandemic: perspectives on the 632 future trajectory of COVID-19

Increased viral variants in children and 635 young adults with impaired humoral immunity and persistent SARS-CoV-2 infection: A 636 consecutive case series

The HADDOCK2.2 639 web server: User-friendly integrative modeling of biomolecular complexes

Omicron variant of SARS-CoV-2 harbors a unique insertion 643 mutation of putative viral or human genomic origin

SWISS-MODEL: homology 647 modelling of protein structures and complexes

The missing expression level-evolutionary rate 649 anticorrelation in viruses does not support protein function as a main constraint on 650 sequence evolution

Eicosanoid signaling as a 653 therapeutic target in middle-aged mice with severe COVID-19. bioRxiv

A new coronavirus associated with human respiratory disease in 657 China

A single dose of an adenovirus-vectored vaccine provides protection 660 against SARS-CoV-2 challenge

SARS-CoV-2 rapidly adapts in aged BALB/c mice and induces typical 663 pneumonia

A pneumonia outbreak associated with a new coronavirus of 666 probable bat origin